Table 5. Comparison 2: bromocriptine versus placebo: drinking days.
Study | Outcome | Experimental group (n=9 completed) | Control group (n=9 completed) | Statistic |
---|---|---|---|---|
Powell 1995 | mean number of drinking days over the 6-month study | 19.0 (no SD provided) (see note 1) | 42.2 (no SD provided) (see note 1) | favours neither condition (see note 2) |
SD = standard deviation
1. figures derived from data presented graphically (Powell 1995, p.467, fig 1); no SDs provided.
2. two-way ANOVA; comorbidity × medication: F(4,89)=2.60; P<0.05; however, Tukey post-hoc tests did not indicate a statistically significant effect for AsPD/bromocriptine subgroup; completer analysis by trial investigators.